Synthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome.
about
Two Isomeric C16 Oxo-Fatty Acids from the Diatom Chaetoceros karianus Show Dual Agonist Activity towards Human Peroxisome Proliferator-Activated Receptors (PPARs) α/γ.From chronic overnutrition to metaflammation and insulin resistance: adipose tissue and liver contributions.An aPPARent Functional Consequence in Skeletal Muscle Physiology via Peroxisome Proliferator-Activated Receptors.Functional Regulation of PPARs through Post-Translational Modifications.Developmental Programming of the Metabolic Syndrome: Can We Reprogram with Resveratrol?Discovery of new FXR agonists based on 6-ECDCA binding properties by virtual screening and molecular docking
P2860
Synthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Synthetic and natural Peroxiso ...... apy of the metabolic syndrome.
@en
Synthetic and natural Peroxisome Proliferator-Activated Receptor
@nl
type
label
Synthetic and natural Peroxiso ...... apy of the metabolic syndrome.
@en
Synthetic and natural Peroxisome Proliferator-Activated Receptor
@nl
prefLabel
Synthetic and natural Peroxiso ...... apy of the metabolic syndrome.
@en
Synthetic and natural Peroxisome Proliferator-Activated Receptor
@nl
P2093
P2860
P1476
Synthetic and natural Peroxiso ...... apy of the metabolic syndrome.
@en
P2093
Chek Kun Tan
Walter Wahli
Yan Zhuang
P2860
P304
P356
10.1080/14728222.2017.1280467
P407
P577
2017-01-16T00:00:00Z